Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4015 results

Sort By:

Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial

Study ID: NCT06274749
Start Date: 2026-03-29
End Date: 2027-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

180

Intervention / Treatment

Urolithin A

Placebo

Sponsor

National Institute on Aging (NIA)

Source: clinicaltrials.gov

Share:
Add to list

Statins Against Bushfire Smoke

Study ID: NCT07462715
Start Date: 2026-05-01
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Phase4

No. of Participants

100

Intervention / Treatment

Atorvastatin

Placebo

Sponsor

Menzies Institute for Medical Research

Source: clinicaltrials.gov

Share:
Add to list

Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)

Study ID: NCT07454499
Start Date: 2026-04-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Digital Endocrine therapy Symptom Monitoring and Education Intervention

Sponsor

Abramson Cancer Center at Penn Medicine

Source: clinicaltrials.gov

Share:
Add to list

Indirect Calorimetry Measurement in the Pediatric Intensive Care Unit's Smallest Patients

Study ID: NCT07462806
Start Date: 2026-04
End Date: 2027-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Q-NRG+

Sponsor

Karolinska Institutet

Source: clinicaltrials.gov

Share:
Add to list

A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer

Study ID: NCT07078604
Start Date: 2026-04-11
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine

Cisplatin

Computed Tomography

Computed Tomography Assisted Biopsy

Docetaxel

Doxorubicin

Eribuli

Paclitaxel

Pegylated Liposomal Doxorubicin Hydrochloride

Sargramostim

Ultrasound-Guided Biopsy

Biospecimen Collection

Carboplatin

Positron Emission Tomography (PET)

Sponsor

University of Washington

Source: clinicaltrials.gov

Share:
Add to list

Implementation Science to Enhance HIV Testing Services During Emergency Care in Kenya

Study ID: NCT06747221
Start Date: 2026-06-01
End Date: 2030-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

184

Intervention / Treatment

Systems Analysis and Improvement Approach (SAIA)

Sponsor

Rhode Island Hospital

Source: clinicaltrials.gov

Share:
Add to list

Peer-modeled Intervention

Study ID: NCT07476716
Start Date: 2026-05-01
End Date: 2026-12-20
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

157

Intervention / Treatment

A peer-modelled behavioural change intervention

Sponsor

KU Leuven

Source: clinicaltrials.gov

Share:
Add to list

CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)

Study ID: NCT05996328
Start Date: 2026-04-15
End Date: 2026-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1400

Intervention / Treatment

Home-delivered meals and short-term dietary counseling

Study -defined standard of care

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Air-Dried Human Amniotic Membrane Terminally Sterilized by Gamma Irradiation for Multidisciplinary Clinical Application

Study ID: NCT07466576
Start Date: 2026-04-01
End Date: 2026-08-02
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

Air-Dried Human Amniotic Membrane (AD-hAM)

Sponsor

Libyan Center for Biotechnology Research

Source: clinicaltrials.gov

Share:
Add to list

H&N NEO-COMBAT XL: Neoadjuvant XL-092 (Zanzalintinib) and Pembrolizumab (Keytruda) in Surgically Resectable, HPV Negative Oral Cavity Squamous Cell Carcinoma (OCSCC)

Study ID: NCT07484139
Start Date: 2026-05
End Date: 2028-05
Study Type

Interventional

Study Phase

Phase2

No. of Participants

26

Intervention / Treatment

XL092

Pembrolizumab

Sponsor

UNC Lineberger Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list